Your browser doesn't support javascript.
loading
Botulinum neurotoxin type-A for primary stabbing headache: an open study / Toxina botulínica do tipo-A para o tratamento da cefaléia primária em punhaladas: um estudo aberto
Piovesan, Elcio Juliato; Teive, Helio Ghizoni; Kowacs, Pedro André; Silva, Lucas Leite da; Werneck, Lineu Cesar.
  • Piovesan, Elcio Juliato; Federal University of Paraná. Hospital de Clínicas. Internal Medicine Department. Headache Unit, Neurology Division. Curitiba. BR
  • Teive, Helio Ghizoni; Federal University of Paraná. Hospital de Clínicas. Internal Medicine Department. Headache Unit, Neurology Division. Curitiba. BR
  • Kowacs, Pedro André; Federal University of Paraná. Hospital de Clínicas. Internal Medicine Department. Headache Unit, Neurology Division. Curitiba. BR
  • Silva, Lucas Leite da; Federal University of Paraná. Hospital de Clínicas. Internal Medicine Department. Headache Unit, Neurology Division. Curitiba. BR
  • Werneck, Lineu Cesar; Federal University of Paraná. Hospital de Clínicas. Internal Medicine Department. Headache Unit, Neurology Division. Curitiba. BR
Arq. neuropsiquiatr ; 68(2): 212-215, Apr. 2010. ilus, tab
Article in English | LILACS | ID: lil-545917
ABSTRACT
Primary stabbing headache is an ultra-short headache, associated with primary headaches, more prevalent in women and with a poor response to therapy. The effect of botulinum neurotoxin type-A (BoNTA) on primary stabbing headache was investigated in 24 patients. Three patients showed complete remission. Nineteen patients showed a decrease in their primary stabbing headaches that started in the second week, and that was sustained during approximately 63 days. In two patients BoNTA showed no therapeutic effect. The BoNTA seems to be an excellent therapeutic option for primary stabbing headache.
RESUMO
Cefaléia primária em punhaladas (CPP) é uma cefaléia ultra-rápida, associada a cefaléias primárias, mais frequente em mulheres e com discreta resposta terapêutica. O efeito da neurotoxina botulínica do tipo A (NTBo-A) sobre a CPP foi investigado em 24 pacientes. Três pacientes apresentaram completa remissão dos sintomas. Dezenove pacientes mostraram uma redução que começou na segunda semana e que manteve-se por um período de 63 dias. Em dois pacientes a NTBo-A não apresentou nenhum efeito terapêutico. A NTBo-A parece ser uma excelente opção terapêutica no tratamento da CPP.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Botulinum Toxins, Type A / Headache Disorders, Primary / Neurotoxins Type of study: Etiology study Limits: Adult / Female / Humans / Male Language: English Journal: Arq. neuropsiquiatr Journal subject: Neurology / Psychiatry Year: 2010 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Paraná/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Botulinum Toxins, Type A / Headache Disorders, Primary / Neurotoxins Type of study: Etiology study Limits: Adult / Female / Humans / Male Language: English Journal: Arq. neuropsiquiatr Journal subject: Neurology / Psychiatry Year: 2010 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Paraná/BR